Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women-Reference-Cited by-同舟云学术

Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women

Published:2019-11 Issue:5 Volume:112 Page:922-929.e2
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Osuga Yutaka,Enya Kazuaki,Kudou Kentarou,Hoshiai Hiroshi

Funder

ASKA Pharmaceutical Co., Ltd

Mochida Pharmaceutical Co., Ltd

Takeda Pharmaceutical Company Limited

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference32 articles.

1. Epidemiology of uterine fibroids: a systematic review;Stewart;BJOG,2017

2. Uterine myomas: An overview of development, clinical features, and management;Wallach;Obstet Gynecol,2004

3. Uterine leiomyomata: etiology, symptomatology, and management;Buttram;Fertil Steril,1981

4. Uterine leiomyoma: understanding the impact of symptoms on womens’ lives;Brito;Reprod Health,2014

5. Alternatives to hysterectomy: the burden of fibroids and the quality of life;Fortin;Best Pract Res Clin Obstet Gynaecol,2018

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ACR Appropriateness Criteria® Management of Uterine Fibroids: 2023 Update;Journal of the American College of Radiology;2024-06

2. Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long‐term extension study: A descriptive subgroup analysis in women with anemia at baseline;International Journal of Gynecology & Obstetrics;2024-04-04

3. The clinical trial of alternative relugolix administration for uterine leiomyoma prior to surgically treatment: a study protocol for Non-Adverse Relugolix Administration (NARA) trial;Trials;2024-01-19

4. Visible-light-induced C(sp³)–H bromination of 4-methylthiophene derivatives with HBr/H₂O₂;Organic & Biomolecular Chemistry;2024

5. Data Mining and Analysis for Safety Signals of Degarelix Based on FAERS;Pharmacy Information;2024